Patents by Inventor Jordi Mestres
Jordi Mestres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240177204Abstract: Systems and methods for attribute determination in a usability study are provided. The system includes the ability to collect screener questions and response pairs and determine the type of question. The question and response pairs may be processed for topic and entity extractions using machine learning (ML) models. From the collected topics and entities, a dictionary of attributes may be generated and eventually expanded/added to as new information regarding the participant becomes available. This attribute dictionary may take the form of a vector dictionary, in some particular embodiments. In some cases, the type of question being posed may dictate how the response is processed. These include a Boolean style question, a quantitative question, a single response question and a multi-response type question.Type: ApplicationFiled: December 7, 2023Publication date: May 30, 2024Inventors: Jordi Ibañez, Laura Bernabe Miguel, David Torres Pascual, Xavier Mestres
-
Patent number: 11941039Abstract: Systems and methods for transcription analysis of a recording are provided. The recording includes an audio and screenshot/video portion. The audio portion is transcribed using a machine learned model. Models may be selected by the recording quality and potentially accents or other speech patterns that are present. The transcription is then linked to the video/screen capture chronology, so that automatic scrolling is enabled, clip selection from the transcription, and searching to a video time is possible. There is improvements to user experience question generation, review of study results, and in managing the study participants.Type: GrantFiled: January 12, 2023Date of Patent: March 26, 2024Assignee: USERZOOM TECHNOLOGIES, INC.Inventors: Xavier Mestres, Alfonso de la Nuez, Albert Recolons, Francesc del Castillo, Jordi Ibañez, Anna Barba, Andrew Jensen
-
Patent number: 11934475Abstract: Advanced user experience study can be accomplished by enabling recording on a device such as a smart phone, providing a participant with one or more survey questions and a task. Typically, the participants are recorded and redirected to a starting URL. The recording can be terminated when the participant reaches a validation condition. Results, for example, videos, survey results, click flows, and heat maps may be filterable across any participant feature or any study validation criteria. Validation criteria includes time taken to complete a given action, ending up at a particular URL (or class of URLs), based upon question answers, or any combination thereof. These criteria can be classified as either a successful completion of the study, or a failed attempt. Additionally, the validation criteria can also include a decision by the participant to abandon the study.Type: GrantFiled: December 30, 2019Date of Patent: March 19, 2024Assignee: USERZOOM TECHNOLOGIES, INC.Inventors: Xavier Mestres, Alfonso de la Nuez, Albert Recolons, Francesc del Castillo, Jordi Ibañez, Anna Barba, Andrew Jensen
-
Patent number: 9000047Abstract: The present invention relates to a compound of formula (I) for use as a medicine, in particular for use in the treatment of diseases mediated by the actvation of the protein kinase Erk1/2, such as neurogenerative illnesses like Alzheimer's and related dementia, epilepsy, Parkinson's disease, Huntington's disease, or stroke, and likewise relates to the pharmaceutical compositions containing said compound. The compound of formula (I) effectively inhibits the activation of the enzyme Erk1/2 induced by the tissue plasminogen activator (TPA) and also effectively inhibits the apoptosis generated by the ?-amyloid peptide.Type: GrantFiled: May 24, 2010Date of Patent: April 7, 2015Assignee: Farmalider, S.A.Inventors: Pilar Navarro Medrano, Elisabet Gregori Puigjane, Marisol Montolio Del Olmo, Ana Jimenez Redondo, Jordi Mestres Lopez
-
Publication number: 20130065966Abstract: The present invention relates to a compound of formula (I) for use as a medicine, in particular for use in the treatment of diseases mediated by the actvation of the protein kinase Erk1/2, such as neurogenerative illnesses like Alzheimer's and related dementia, epilepsy, Parkinson's disease, Huntington's disease, or stroke, and likewise relates to the pharmaceutical compositions containing said compound. The compound of formula (I) effectively inhibits the activation of the enzyme Erk1/2 induced by the tissue plasminogen activator (TPA) and also effectively inhibits the apoptosis generated by the ?-amyloid peptide.Type: ApplicationFiled: May 24, 2010Publication date: March 14, 2013Applicant: FARMALIDER, S.A.Inventors: Pilar Navarro Medrano, Elisabet Gregori Puigjane, Marisol Montolio Del Olmo, Ana Jimenez Redondo, Jordi Mestres Lopez
-
Patent number: 7838518Abstract: The present invention relates to 1-arylsulfonyl-3 substituted indole or indoline derivatives having the general formula (I) (I) wherein the dotted line represents an optional bond; n is 0 or 1; m is 0-5 and Ar, R6-R11 are defined in the description. The invention further relates to pharmaceutical compositions comprising said derivatives, and to the use of these 1-arylsulfonyl-3-substituted indole or indoline derivatives in the treatment of central nervous disorders such as psychosis, schizophrenia, manic depressions, depressions, neurological disorders, cognitive enhancement, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease.Type: GrantFiled: February 5, 2003Date of Patent: November 23, 2010Assignee: N.V. OrganonInventors: Daniel Spinks, Richard E. Armer, David J. Miller, Zoran Rankovic, Gayle Spinks, Jordi Mestres, David Robert Jaap
-
Patent number: 7696190Abstract: The invention makes a 16?-substituted steroidal compound available having formula 1, wherein the dotted ring is a fully saturated, a fully aromatic or a saturated ring with a ?5-10 double bond; R1 is (C1-C3)alkyl or (C2-C3)alkenyl, and each of these groups can be substituted with one or more halogens; R2 is (C1-C4;)alkyl, (C2-C4)alkenyl or methylene, and each of these groups can be substituted with one or more halogens; R3 is methyl or ethyl; or a prodrug thereof, which compound can be used for an estrogen receptor ? selective treatmentType: GrantFiled: July 23, 2001Date of Patent: April 13, 2010Assignee: N.V. OrganonInventors: Jordi Mestres, Hubert Jan Jozef Loozen, Gerrit Herman Veeneman
-
Publication number: 20100029603Abstract: The invention makes a 16?-substituted steroidal compound available having formula 1, wherein the dotted ring is a fully saturated, a fully aromatic or a saturated ring with a ?5-10 double bond; R1 is (C1-C3)alkyl or (C2-C3)alkenyl, and each of these groups can be substituted with one or more halogens; R2 is (C1-C4)alkyl, (C2-C4)alkenyl or methylene, and each of these groups can be substituted with one or more halogens; R3 is methyl or ethyl; or a prodrug thereof, which compound can be used for an estrogen receptor ? selective treatment.Type: ApplicationFiled: May 29, 2009Publication date: February 4, 2010Inventors: Jordi Mestres, Hubert Jan Jozef Loozen, Gerrit Herman Veeneman
-
Patent number: 7076350Abstract: An energy management system for controlling an electrical system comprises data collection components, such as sensors, for providing quantified variables for forming an instantaneous state vector. A time series predictor generates an estimated future vector value in response to the instantaneous state vector. An electrical system manager includes predetermined decision rules invoked in response to the estimated future vector value to adapt the electrical system to expected electrical conditions.Type: GrantFiled: December 19, 2003Date of Patent: July 11, 2006Assignee: Lear CorporationInventors: Ignacio Álvarez-Troncoso, Joan Fontanilles Piñas, Jordi Mestre Guasch
-
Patent number: 6943327Abstract: Disclosed is a method particularly applicable to an automotive vehicle seat, through which the control of heating of heating elements is carried out by an electronic circuit, based on the temperature monitored in the heating elements and using Pulse Width Modulation (PWM). The signals applied to the heating elements are progressively adapted to the condition of the different heating elements at all times and throughout their useful life, by variation of the working cycle of the signal applied to the heating elements in the form of a fixed frequency pulse train, and applying said signal after an initial transient state, during which state a maximum voltage has been applied to the heating elements and has been maintained until reaching a desired percentage of an assigned temperature by each of said heating elements.Type: GrantFiled: February 4, 2004Date of Patent: September 13, 2005Assignee: Lear CorporationInventors: Antoni Ferre Fabregas, Alberto Garcia Briz, Joan Fontanilles Pinas, Jordi Mestre Gausch, Rudolf Diemer, Stefan Jost
-
Publication number: 20050167418Abstract: Disclosed is a method particularly applicable to an automotive vehicle seat, through which the control of heating of heating elements is carried out by an electronic circuit, based on the temperature monitored in the heating elements and using Pulse Width Modulation (PWM). The signals applied to the heating elements are progressively adapted to the condition of the different heating elements at all times and throughout their useful life, by variation of the working cycle of the signal applied to the heating elements in the form of a fixed frequency pulse train, and applying said signal after an initial transient state, during which state a maximum voltage has been applied to the heating elements and has been maintained until reaching a desired percentage of an assigned temperature by each of said heating elements.Type: ApplicationFiled: February 4, 2004Publication date: August 4, 2005Applicant: Lear CorporationInventors: Antoni Ferre Fabregas, Alberto Garcia Briz, Joan Fontanilles Pinas, Jordi Mestre Gausch, Rudolf Diemer, Stefan Jost
-
Publication number: 20050154023Abstract: The present invention relates to 1-arylsulfonyl-3-substituted indole or indoline derivatives having the general formula I wherein the dotted line represents an optional bond; n is 0 or 1; m is 0-5 and Ar, R6-R11, are defined in the description. The invention further relates to pharmaceutical compositions comprising said derivatives, and to the use of these 1-arylsulfonyl-3-substituted indole or indoline derivatives in the treatment of central nervous disorders such as psychosis, schizophrenia, manic depressions, depressions, neurological disorders, cognitive enhancement, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease.Type: ApplicationFiled: February 5, 2003Publication date: July 14, 2005Inventors: Daniel Spinks, Richard Armer, David Miller, Zoran Rankovic, Gayle Spinks, Jordi Mestres, David Jaap
-
Patent number: 6756375Abstract: The invention provides for a non-steroidal compound having the formula wherein Re and ′Re are OH, optionally independently etherified or esterified; Z is —CH2— or —CH2CH2—; R1 is H, halogen, CF3, or (1C-4C)alkyl; R2, R3 and R4 are independently H, halogen, —CF3, —OCF3, (1C-8C)Alkyl, hydroxy, (1C-8C)alkyloxy, aryloxy, aryl(1C-8C)alkyl, halo(1C-8C)alkyl, —O(CH2)mX, wherein X is halogen or phenyl and m=2-4; —O(CH2)mNRaRb, —S(CH2)mNRaRb or —(CH2)mNRaRb, wherein m=2-4 and Ra, Rb are independently (1C-8C)alkyl, (2C-8C)alkenyl, (2C-8C)alkynyl, or aryl, optionally substituted with halogen, —CF3, —OCF3, —CN, —NO2, —OH, (1C-8C)alkoxy, aryloxy, carboxyl, (1C-8C)alkylthio, carboxylate, (1C-8C)alkyl, aryl, aryl(1C-8C)alkyl, halo(1C-8C)alkyl or Ra and Rb form a 3-8 membered ring structure, optionally substituted with halogen, —CF3, —OCF3, —CN, —NO2, hydroxy, hydroxy(1C-4C)aType: GrantFiled: July 24, 2003Date of Patent: June 29, 2004Assignee: Akzo Nobel N.V.Inventors: Gerrit Herman Veeneman, Hubert JanJozef Loozen, Jordi Mestres, Eduard Willem De Zwart
-
Publication number: 20040059004Abstract: The invention provides for a non-steroidal compound having the formula 1Type: ApplicationFiled: July 24, 2003Publication date: March 25, 2004Inventors: Gerrit Herman Veeneman, Hubert JanJozef Loozen, Eduard Willem De Zwart, Jordi Mestres
-
Publication number: 20040043976Abstract: The invention makes a 16&agr;-substituted steroidal compound available having formula 1, wherein the dotted ring is a fully saturated, a fully aromatic or a saturated ring with a &Dgr;5-10 double bond; R1 is (C1-C3)alkyl or (C2-C3)alkenyl, and each of these groups can be substituted with one or more halogens; R2 is (C1-C4;)alkyl, (C2-C4)alkenyl or methylene, and each of these groups can be substituted with one or more halogens; R3 is methyl or ethyl; or a prodrug thereof, which compound can be used for an estrogen receptor &agr; selective treatment.Type: ApplicationFiled: July 17, 2003Publication date: March 4, 2004Inventors: Jordi Mestres, Hubert Jan Jozef Loozen, Gerrit Herman Veeneman
-
Patent number: 6686371Abstract: The invention provides non-steroidal estrogenic compounds with estrogenic and anti-estrogenic compounds effects for treatment of estrogen-deficiency related disorders, which compounds are having formula (I) wherein, one of Ra or Rb is 'Re; Re and 'Re are OH, optionally independently etherified or esterified; X is N or —C(R1)—, wherein R1 is H1 halogen, CN, optionally substituted aryl, (1C-4C)alkyl, (2C-4C)alkenyl, (2C-4C)alkynyl or (3C-6C)cycloalkyl, which alkyl, alkenyl, alkynyl and cycloalkyl groups can optionally be substituted with one or more halogens; Y is N or —C(R2)—, with the proviso that X and Y are not both N, wherein R2 has the same meaning as defined for R1; Z is C(R3,'R3)— or —C(R4,∝R4)—C(R5,'R5)—, wherein R3, 'R3, R4, 'R4, R5, and 'R5, independently arc H, (1C-4C)alkyl, (2C-4C)alkenyl or (3C-6C) cycloalkyl, which alkyl, alkenyl and cycloalkyl groups can optionally be substituted with one or more halogens.Type: GrantFiled: December 2, 2002Date of Patent: February 3, 2004Assignee: Akzo Nobel N.V.Inventors: Gerrit Herman Veeneman, Eduard Willem De Zwart, Hubert Jan Jozef Loozen, Jordi Mestres
-
Publication number: 20030144313Abstract: The invention provides non-steroidal estrogenic compounds with estrogenic and anti-estrogenic compounds effects for treatment of estrogen-deficiency related disorders, which compounds are having formula (I) wherein, one of Ra or Rb is 'Re; Re and 'Re are OH, optionally independently etherified or esterified; X is N or —C(R1)—, wherein R1 is H, halogen, CN, optionally substituted aryl, (1C-4C)alkyl, (2C-4C)alkenyl, (2C-4C)alkynyl or (3C-6C)cycloalkyl, which alkyl, alkenyl, alkynyl and cycloalkyl groups can optionally be substituted with one or more halogens; Y is N or —C(R2)—, with the proviso that X and Y are not both N, wherein R2 has the same meaning as defined for R1; Z is C(R3,'R3)— or —C(R4,'R4)—C(R5,'R5)—, wherein R3, 'R3, R4, 'R4, R5, and 'R5, independently arc H, (1C-4C)alkyl, (2C-4C)alkenyl or (3C-6C) cycloalkyl, which alkyl, alkenyl and cycloalkyl groups can optionally be substituted with one or more halogens.Type: ApplicationFiled: December 2, 2002Publication date: July 31, 2003Inventors: Gerrit Herman Veeneman, Eduard Willem De Zwart, Hubert Jan Jozef Loozen, Jordi Mestres